v-Myb suppresses phorbol ester- and modifies retinoic acid-induced differentiation of human promonocytic U937 cells

Neoplasma

Volumn 55, Issue 4, 2008, Pages 286-293

  Knopfova, L ^a   Smarda, J ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Differentiation; Macrophage; Phorbol ester; Retinoic acid; U937; v Myb

Indexed keywords

PHORBOL ESTER; RETINOIC ACID;

ARTICLE; AVIAN MYELOBLASTOSIS VIRUS; CELL DIFFERENTIATION; CELL STRAIN U937; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; MYELOPOIESIS; ONCOGENE; ONCOGENE V MYB; DRUG EFFECT; GENETIC TRANSFECTION; GRANULOCYTE; MACROPHAGE; ONCOGENE MYB; VIRUS CELL TRANSFORMATION;

CELL DIFFERENTIATION; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION; GENES, MYB; GRANULOCYTES; HUMANS; MACROPHAGES; MONOCYTES; PHORBOL ESTERS; TRANSFECTION; TRETINOIN; U937 CELLS;

EID: 49949088270     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. MUCENSKI ML, MCLAIN K, KIER AB et al.: A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991; 65: 677-689.
2. CRAIG RW, BLOCH A. Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1984; 44: 442-446.
3. TODOKORO K, WATSON RJ, HIGO H et al.: Down-regulation of c-myb gene expression is prerequisite for erythropoietin-induced erythroid differentiation. Proc. Natl. Acad. Sci. USA 1988; 85: 8900-8904.
4. DUPREY SP, BOETTIGER D. Developmental regulation of c-myb in normal myeloid progenitor cells. Proc Natl Acad Sci USA 1985; 82: 6937-6941.
5. YANAGISAWA H, NAGASAWA T, KURAMOCHI S et al.: Constitutive expression of exogenous c-myb gene causes maturation block in monocyte-macrophage differentiation. Biochim Biophys Acta 1991; 1088: 380-384.
6. BIES J, HOFFMAN B, AMANULLAH A et al.: B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene 1996; 12: 355-363.
7. WOLFF L, KOLLER R, BIES J et al.: Retroviral insertional mutagenesis in murine promonocytic leukemias: c-myb and Mml1. Curr Top Microbiol Immunol 1996; 211: 191-199. (Pubitemid 26019279)
8. BIES J, MUKHOPADHYAYA R, PIERCE J et al.: Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms. Cell Growth Differ 1995; 6: 59-68.
9. PATEL G, TANTRAVAHI R, OH IH et al.: Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells. Oncogene 1996; 13: 1197-1208.
10. ENGELHARD A, CAMPBELL K, CALABRETTA B. Bmyb alters the response of myeloid precursor cells to G-CSF. Exp Cell Res 2000; 254: 153-162.
11. CLARKE MF, KUKOWSKA-LATALLO JF et al.: Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol 1988; 8: 884-892.
12. McCLINTON D, STAFFORD J, BRENTS L et al.: WM. Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Mol Cell Biol 1990; 10: 705-710.
13. DANISH R, el-AWAR O, WEBER BL et al.: c-myb effects on kinetic events during MEL cell differentiation. Oncogene 1992; 7: 901-907.
14. NASON-BURCHENAL K, WOLFF L. Activation of c-myb is an early bone-marrow event in a murine model for acute promonocytic leukemia. Proc Natl Acad Sci USA 1993; 90: 1619-1623. (Pubitemid 23058225)
15. WOLFF L, KOLLER R, DAVIDSON W. Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integration involve c-myb in some but not all leukemias. J Virol 1991; 65: 3607-3616.
16. GOLDMAN J, McGUIRE WA. Oncogene RNA expression in three human lymphoblastic leukemia cell lines lymphocytes. Pediatr Hematol Oncol 1992; 9: 57-63.
17. MAVILIO F, SPOSI NM, PETRINI M et al.: Expression of cellular oncogenes in primary cells from human acute leukemias. Proc Natl Acad Sci USA 1986; 83: 4394-4398. (Pubitemid 16057054)
18. OHYASHIKI K, OHYASHIKI JH, KINNIBURGH AJ et al.: Myb oncogene in human hematopoietic neoplasia with 6q-anomaly. Cancer Genet Cytogenet 1988; 33: 83-92.
19. PELICCI PG, LANFRANCONE L, BRATHWAITE MD et al.: Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 1984; 224: 1117-1121. (Pubitemid 14106391)
20. THOMPSON MA, FLEGG R, WESTIN EH et al.: Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines. Oncogene 1997; 14: 1715-1723.
21. BARLETTA C, LAZZARO D, PROSPERI PORTA R et al.: c-MYB activation and the pathogenesis of ovarian cancer. Eur J Gynaecol Oncol 1992; 13: 53-59.
22. BEUG H, von KIRCHBACH A, DODERLEIN G et al.: Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell 1979; 18: 375-390.
23. RADKE K, BEUG H, KORNFELD S et al.: Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene. Cell 1982; 31: 643-653.
24. SYMONDS G, KLEMPNAUER KH, EVAN GI et al.: Induced differentiation of avian myeloblastosis virus-transformed myeloblasts: phenotypic alteration without altered expression of the viral oncogene. Mol Cell Biol 1984. 4: 2587-2593.
25. SMARDA J, LIPSICK JS. c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts. Oncogene 1994; 9: 237-245. (Pubitemid 2021067)
26. NEMAJEROVA A, SMARDA J, JURDIC P et al.:J. Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells. J Hematother Stem Cell Res 2003; 12: 225-235.
27. BENES P, MACECKOVA V, ZATLOUKALOVA J et al.: Retinoic acid enhances differentiation of v-myb-transformed monoblasts induced by okadaic acid. Leuk Res 2007; 31: 1421-1431.
28. SMARDA J, SUGARMAN J, GLASS C et al.: Retinoic acid receptor á suppresses transformation by v-myb. Mol Cell Biol 1995; 15: 2474-2481.
29. SMARDA J, ZEMANOVA K, BRYJA J et al.: Retinoid X receptor suppresses transformation by the v-myb oncogene. J Leukoc Biol 1999; 66: 1039-1048
30. SEVCIKOVA S, SOUCEK K, KUBALA L et al.: Differential effects of v-Jun and c-Jun proteins on v-myb-transformed monoblast. Cell Mol Life Sci 2002; 59: 1690-1705.
31. NAVRATILOVA J, HORVATH V, KOZUBIK A et al.: p53 arrests growth and induces differentiation of v-Myb-transformed monoblasts. Differentiation 2007; 75: 592-604.
32. HASS R, BARTELS H, TOPLEY N et al.: TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. Eur J Cell Biol 1989; 48: 282-293.
33. TWOMEY BM, MCCALLUM S, ISENBERG DA et al.: Elevation of heat shock protein synthesis and hsp gene transcription during monocyte to macrophage differentiation of U937 cells. Clin Exp Immunol 1993; 93: 178-183.
34. SHEPHERD MC, BAILLIE GS, STIRLING DI et al.: Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells. Br J Pharmacol 2004; 142: 339-351.
35. NAKAJIMA H, KIZAKI M, MUTO A et al.: All-trans and 9-cis retinoic acid enhance 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells. Leuk Res 1996; 20: 665-676.
36. OLSSON IL, BREITMAN TR. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′:5′-monophosphate-inducing agents. Cancer Res 1982; 42: 3924-3927.
37. SUNDSTRÖM, C., NILSSON, K. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17: 565-577.
38. SMARDA J, LIPSICK JS. Dicistronic selection for nuclear proteins in living animal cells. Gene 1993; 137: 145-149.
39. SOUTHERN PJ, BERG P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1982; 1: 327-341
40. SLEEMAN JP. Xenopus A-myb is expressed during early spermatogenesis. Oncogene 1993; 8: 1931-1941. (Pubitemid 23212427)
41. DRAYSON MT, MICHELL RH, DURHAM J et al.: Cell proliferation and CD11b expression are controlled independently during HL60 cell differentiation initiated by 1,25α-dihydroxyvitamin D3 or all-trans retinoic acid. Exp Cell Res 2001; 266: 126-134.
42. NOJIRI H, TAKAKU F, TERUI Y et al.: Ganglioside GM3: an acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937. Proc Natl Acad Sci USA 1986; 83: 782-786.
43. OLINS, AL, HERRMANN H, LICHTER P et al.: Nuclear envelope and chromatin compositional differences comparing undifferentiated and retinoic acid- and phorbol ester-treated HL-60 cells. Exp Cell Res 2001; 268: 115-127.
44. KASTAN MB, SLAMON DJ, CIVIN CI. Expression of protooncogene c-myb in normal human hematopoietic cells. Blood 1989; 73: 1444-1451. (Pubitemid 19131885)
45. GONDA TJ, METCALF D. Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia. Nature 1984; 310: 249-251.
46. LEE J, MEHTA K, BLICK MB et al.: G. Expression of cfos, c-myb, and c-myc in human monocytes: correlation with monocytic differentiation. Blood 1987; 69: 1542-1545.
47. SHEN-ONG GL, MORSE HC, POTTER M et al.: Two modes of c-myb activation in virus-induced mouse myeloid tumors. Mol Cell Biol 1986; 6: 380-392.
48. WEINSTEIN Y, IHLE JN, LAVU S et al.: Truncation of the c-myb gene by retroviral integration in an interleukin 3-dependent myeloid leukemia cell line. Proc Natl Acad Sci USA 1986; 83: 5010-5014.
49. GONDA TJ, CORY S, SOBIESZCZUK P et al.: Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias. J Virol 1987; 61: 2754-2760.
50. CLAPPIER E, CUCCUINI W, KALOTA A et al.: The CMYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (TALL), the translocation defining a new T-ALL subtype in very young children. Blood 2007; 15: 1251-1261.
51. WANG ZY, CHEN Z, HUANG W et al.: Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA). Blood Cells 1993; 19: 633-641.
52. ZHOU GB, ZHANG J, WANG ZY et al.: Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy. Philos Trans R Soc Lond B Biol Sci 2007; 362: 959-971. (Pubitemid 47056795)
53. SELVAKUMARAN M, LIEBERMANN DA, HOFFMANLIEBERMANN B. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor- induced myeloid differentiation prior to c-myc- role in leukemogenesis. Mol Cell Biol 1992; 12: 2493-2500.
54. PATEL G, KREIDER B, ROVERA G et al.: v-myb blocks granulocyte colony-stimulating factor-induced myeloid cell differentiation but not proliferation. Mol Cell Biol 1993; 13: 2269-2276. (Pubitemid 23097705)
55. FERRARI S, DONELLI A, MANFREDINI R et al.: Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells. Cell. Growth Differ. 1990; 1: 543-548.
56. IVANOVA O, BRAAS D, KLEMPNAUER KH. Oncogenic point mutations in the Myb DNA-binding domain alter the DNA-binding properties of Myb at a physiological target gene. Nucleic Acids Res 2007; 1-11.